Molecular Subtype
ALK-Positive Large B-Cell Lymphoma
CI-CAN-00007196Explore in graph →
Hematologic5 active trials
Loading cancer entity…
Loading cancer entity…
Molecular Subtype
CI-CAN-00007196Explore in graph →
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-13 | 79 | ("ALK-Positive Large B-Cell Lymphoma"[tiab] OR "ALK-DLBCL"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length ALK"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length Anaplastic Lymphoma Kinase"[tiab]) | 2026-09-13 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 34 | ("ALK-Positive Large B-Cell Lymphoma"[tiab] OR "ALK-DLBCL"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length ALK"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length Anaplastic Lymphoma Kinase"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-13 | pubmed |
| Last 12 months | 2025-09-13 → 2026-09-13 | 9 | ("ALK-Positive Large B-Cell Lymphoma"[tiab] OR "ALK-DLBCL"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length ALK"[tiab] OR "Diffuse Large B-Cell Lymphoma with Expression of Full-Length Anaplastic Lymphoma Kinase"[tiab]) AND (2025/09/13:2026/09/13[dp]) | 2026-09-13 | pubmed |
Data updated 17 days agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
Data not yet available